Donor t cells aim to fight severe COVID-19
Disease control
Ongoing
This early-stage trial tests a therapy made from donor immune cells, called LB-DTK-COV19, in adults with severe COVID-19. The cells are designed to target the virus and are given as a single infusion. The study aims to find a safe dose and see if the treatment can improve symptom…
Phase: PHASE1 • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC